This past weekend, there were reports circulating regarding one Andy Serkis potentially directing Venom 2. In case you missed it, our own Kyle Malone reported on a THR report that Sony sat down with the renowned actor to potentially take on the sequel to the highly-profitable anti-hero film, which of course, had Tom Hardy taking on the roles of Eddie Brock and Venom himself.

But who’s to say this is something that would actually bear fruit? Well, we may have an indication that these talks are going quite well. The folks over at CBM have noticed an interesting post from Hardy himself, which features an image of Serkis. The post featured no caption, but seems quite suspect, given the news.

RELATED – Andy Serkis May Direct Venom 2 | LRMornings

To add to the fire, the post was deleted not long after…hence why I couldn’t simply embed the tweet. The outlet was able to grab a screencap of the post before it was taken down, however, which you can check in the source link down below. All in all, it does seem to indicate some sort of legit rumblings at least.

Like many people, I’m a huge fan of Serkis as an actor, but I’ll admit, his directorial efforts have eluded me. This includes his Mowgli film, whose VFX looked all too uncanny valley for me to want to check out. As such, I can’t speak to his skill as a director. But it’s an interesting choice nonetheless, if true.

What do you think of this? Will Serkis direct Venom 2, and if so, is it a good idea? Let us know your thoughts down below!

Don’t forget to share this post on your Facebook wall and with your Twitter followers! Just hit the buttons on the top of this page.

—–

Have you checked out LRM Online‘s official podcast feed yet The LRM Online Podcast Network, which includes our flagship podcast Los Fanboys, our premiere podcast Breaking Geek Radio: The Podcast, and our morning show LRMornings? Check it out by listening below. It’s also available on all your favorite podcast apps!

Subscribe on: Apple Podcasts |  Spotify  |  SoundCloud | Stitcher | Google Play

SOURCE: CBM